Aymeric Ravel-Chapuis

10PUBLICATIONS
17CO-AUTHORS
Exercise physiologyMedical infection agents (incl. prions)MechanobiologyEnergy generation, conversion and storage (excl. chemical and electrical)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 19, 2026
Exercise mimetics as unexplored therapeutics for treating depression.

Nicholas Fabiano, Jess G Fiedorowicz, Aymeric Ravel-Chapuis

|Nov 28, 2025
Dystrophic Skeletal Muscle Phenotypes Can Be Horizontally Transferred via Fecal Microbiome Transplantations.

James Butcher, Jessica T Gosse, Jonathan Gobin

|Nov 29, 2024
The AMPK allosteric activator MK-8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle.

Aymeric Ravel-Chapuis, Chimène Fahmi, Jonathan Gobin

|Feb 25, 2023
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

Nafisa Neault, Aymeric Ravel-Chapuis, Stephen D Baird

|Nov 19, 2022
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.

Alexis Osseni, Aymeric Ravel-Chapuis, Edwige Belotti

|Sep 01, 2022
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.

Naomi S Misquitta, Aymeric Ravel-Chapuis, Bernard J Jasmin

Pageof 2

Frequent Collaborators

6 joint publications

Bernard J Jasmin

2 joint publications

Jonathan Gobin

1 joint publications

Kyle N Cowan

1 joint publications

Shekoufeh Almasi